Skip to main content
TipRanks
Go Ultimate75% OFF

Kontigo Care AB (3KT) AI Stock Analysis

0 Followers
DE:3KT

Kontigo Care AB

(Frankfurt:3KT)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Strong Revenue ReaccelerationThe sharp TTM revenue rebound indicates renewed demand for Kontigo Care’s monitoring solutions and supports a stronger operating base over the next several quarters. If sustained, this growth can improve scale economics, reinforce customer adoption, and provide a foundation for eventual profitability.
Negative Factors
Persistent TTM LossesOperating and net losses indicate that current revenue levels are not yet sufficient to cover the full cost structure on a durable basis. Continued losses can constrain reinvestment, weaken returns on equity, and make future performance dependent on achieving further scale or improving margins.

Kontigo Care AB (3KT) vs. iShares MSCI Germany ETF (EWG)

-100%-75%-50%-25%0%25%50%DE:3KT-46.34%EWG+9.26%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 4.11M
Dividend Yield
―
Average Volume (3M)
―
Price to Earnings (P/E)
-42.4
Beta (1Y)
0.86
Revenue Growth
4.45%
EPS Growth
39.53%
Country
Germany
Employees
11
Sector
Healthcare
Sector Strength
51
Industry
Medical - Healthcare Information Services

Kontigo Care AB Business Overview & Revenue Model

Company Description

Kontigo Care AB (publ) specializes in delivering healthcare solutions aimed at addressing addiction issues within Sweden. Their product portfolio includes Previct Alcohol, a digital medical device designed to manage alcohol dependence, and Previct Ga...

Kontigo Care AB Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:3KT against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
SE:PTRKSE:PTRK59NeutralSEK 178.06M-2.04――-10.30%-11.59%
SE:SEZISE:SEZI55NeutralSEK 532.17M-5.46-35.44%―18.56%28.11%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
SE:MNTCSE:MNTC51NeutralSEK 475.32M-25.18-15.00%―11.18%60.51%
SE:AINOSE:AINO38UnderperformSEK 37.03M-3.54105.04%―-10.72%-77.78%
SE:QLIFESE:QLIFE38UnderperformSEK 25.35M-0.651852.00%―142.55%73.84%

* Healthcare Sector Average

Performance Comparison

-50%0%50%100%DE:3KTSE:SEZISE:QLIFESE:AINOSE:MNTCSE:PTRKDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:3KT and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:3KTKontigo Care AB0.07-0.06-45.90%
SE:SEZISenzime AB3.38-1.57-31.62%
SE:QLIFEQlife Holding AB0.88-0.61-40.99%
SE:AINOAino Health AB0.180.016.47%
SE:MNTCMentice AB16.902.9521.15%
SE:PTRKPhysitrack Limited10.95-3.50-24.22%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.